HomeSTOK • NASDAQ
Stoke Therapeutics Inc
add
$30.50
11.68%
After Hours:(0.92%)+0.28
$30.78
Closed: Oct 8, 7:44:33 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 13.82M | 186.01% |
Operating expense | 41.12M | 20.32% |
Net income | -23.48M | 8.61% |
Net profit margin | -169.96 | 68.05% |
Earnings per share | -0.40 | 13.04% |
EBITDA | -26.85M | 6.74% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 247.71M | -12.15% |
Total assets | 384.51M | 24.94% |
Total liabilities | 49.57M | -23.80% |
Total equity | 334.94M | — |
Shares outstanding | 54.80M | — |
Price to book | 4.46 | — |
Return on assets | -17.25% | — |
Return on capital | -19.70% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -23.48M | 8.61% |
Cash from operations | -25.42M | -45.46% |
Cash from investing | -148.48M | -68.19% |
Cash from financing | 554.00K | -99.54% |
Net change in cash | -173.35M | -1,263.78% |
Free cash flow | -18.88M | -955.21% |
Previous close
$27.31
Day range
$27.15 - $32.40
Year range
$5.35 - $32.40
Market cap
1.67B USD
Avg Volume
997.67K
P/E ratio
36.09
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Headquarters
Website
Employees
128
